Literature DB >> 13158670

Laboratory aspects of tuberculosis in the ambulatory patient.

D WIDELOCK, A B ROBINS.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY

Mesh:

Year:  1954        PMID: 13158670      PMCID: PMC1620752          DOI: 10.2105/ajph.44.6.794

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN: 0002-9572


× No keyword cloud information.
  4 in total

1.  Susceptibility to isoniazid and pathogenicity of tubercle bacilli.

Authors:  H BLOCH; D WIDELOCK; L R PEIZER
Journal:  Am Rev Tuberc       Date:  1953-11

2.  Virulence of tubercle bacilli recovered from patients treated with isoniazid.

Authors:  W STEENKEN; E WOLINSKY
Journal:  Am Rev Tuberc       Date:  1953-10

3.  Virulence in guinea pigs of isoniazidresistant cultures isolated from clinical specimens; a preliminary report.

Authors:  L R PEIZER; D WIDELOCK; S KLEIN
Journal:  Am Rev Tuberc       Date:  1953-08

4.  Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli.

Authors:  G MIDDLEBROOK; M L COHN
Journal:  Science       Date:  1953-09-11       Impact factor: 47.728

  4 in total
  4 in total

1.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

2.  Public health significance of tubercle bacilli resistant to isoniazid.

Authors:  D WIDELOCK; L R PEIZER; S KLEIN
Journal:  Am J Public Health Nations Health       Date:  1955-01

3.  A program of home chemotherapy for tuberculosis in Baltimore.

Authors:  C SILVERMAN
Journal:  Am J Public Health Nations Health       Date:  1955-10

4.  CHANGES in isoniazid resistance of tubercle bacilli after cessation of treatment; report by the Laboratory Subcommittee of the Tuberculosis Chemotherapy Trials Committee, Medical Research Council; M.R.C. isoniazid trial: Report No. 6.

Authors: 
Journal:  Thorax       Date:  1954-12       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.